Kisspeptin-10 (5mg) protocols focus on this short-chain neuropeptide that plays a key role in regulating the hypothalamic–pituitary–gonadal (HPG) axis. Kisspeptin-10 stimulates the release of gonadotropin-releasing hormone (GnRH), which can influence downstream testosterone, estrogen, and reproductive hormone activity. This guide outlines a subcutaneous administration approach optimized for the 5 mg vial format.
Concise summary of the subcutaneous regimen.
Suggested approach for the 5 mg vial format.
Kisspeptin-10 is a biologically active fragment of the kisspeptin peptide family, acting primarily on the KISS1 receptor (GPR54) located in the hypothalamus. Activation of this receptor stimulates the release of GnRH (gonadotropin-releasing hormone), which in turn signals the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH).
This hormonal cascade plays a central role in regulating reproductive function, including testosterone production in males and ovulatory cycles in females. Research suggests kisspeptin signaling is a key upstream regulator of puberty, fertility, and overall endocrine balance.
Observations based on preclinical and early-stage research.
Potential Benefits:
Possible Side Effects: